Co-Investment Programs: When They're a Real Benefit
Not every co-invest offer is a gift — some are just a way to move cost and concentration onto your balance sheet.
Co-investment programs have become a standard feature of GP marketing decks. The pitch is straightforward: invest alongside the fund at reduced or zero fees, get direct exposure to a single asset, deepen the relationship. What the deck rarely articulates is the selection mechanism operating underneath — and that mechanism determines whether the opportunity is genuine alignment or structured offload.
Why Co-Invests Exist in the First Place
Most co-investment inventory emerges from one of two situations. Either the deal is larger than the fund’s concentration limits allow, creating authentic overflow that the GP wants to place with trusted LPs. Or the deal has softened since initial underwriting — competitive dynamics shifted, diligence surfaced complexity, or the valuation proved sticky — and the GP needs to fill the round without repricing.
The first situation represents real alignment. The GP is already committed through the fund vehicle and is inviting the LP to participate on identical economics. The second situation is structurally different: the co-invest offer functions as a distribution mechanism for inventory the fund either cannot or will not absorb at current terms.
Reading the Structure, Not the Story
Three structural signals separate genuine co-invest programs from fee-shifting instruments. First, GP fund participation: if the main fund is meaningfully invested in the same asset at the same entry price, incentives are largely symmetrical. If the fund took a small anchor position specifically to enable the co-invest syndication, the economics are inverted.
Second, timeline of the offer. Co-invests surfaced during or shortly after initial fund diligence reflect authentic overflow. Offers that arrive 12–18 months post-close, when the company needs a growth or bridge round, deserve heavier scrutiny — particularly if the fund itself is not participating pro rata in the new round.
- GP fund participation in the same round, at the same price point
- Offer timing relative to original fund close and company trajectory
- Whether the co-invest carries full information rights or operates on condensed diligence timelines
- Concentration as a percentage of the GP’s total portfolio exposure to that sector
Third, information asymmetry. A GP sitting on 18 months of board-level data offering a 30-day co-invest window to LPs reviewing a 40-page memo is a structural mismatch. Compressed timelines are a feature of the instrument, not an accident.
When the Structure Genuinely Favors the LP
Co-invests from established managers with long-standing LP relationships and auditable track records on co-invest exits do show a measurable pattern: lower fee drag and direct exposure to the GP’s highest-conviction positions. The fee elimination — typically a 1.5–2% management fee and 20% carry reduction relative to the fund — is economically meaningful over a five to seven year hold. The asset is also visible in a way blind-pool fund exposure is not, which suits capital allocators running concentrated, transparent portfolios.
The more durable advantage is information quality over time. LPs who co-invest tend to receive ongoing portfolio company communications, which compounds into better judgment on subsequent decisions — including whether to participate in follow-on rounds or secondary transactions in the same asset.
The Operator Read
The co-invest offer worth taking is one where the GP has more skin in the same trade than you do, offered it before the story got complicated, and is providing the same data their own investment committee reviewed. That set is smaller than the volume of co-invest decks currently circulating. Operators and allocators who treat co-invest access as a relationship benefit to be evaluated deal-by-deal — rather than a program to opt into — tend to build cleaner, more legible direct exposure over time.
The conversations that move outcomes happen in private rooms.
The Marczell Klein Platinum Partnership is a high-proximity ecosystem for operators, investors, and entrepreneurs. By application only.
Apply for Platinum Access →Editorial & market-views disclosure. This article expresses general market views, observations, and educational commentary. It is not financial, investment, legal, tax, or accounting advice; not a recommendation to buy, sell, hold, or otherwise transact in any security, asset, or instrument; and not personalized to any reader’s circumstances. Markets are uncertain and capital can be lost in part or in whole.
No advisory relationship. Neither Marczell Klein nor Marczell Klein Corp acts as a broker-dealer, registered investment adviser, municipal advisor, commodity trading advisor, crowdfunding portal, fiduciary, or placement agent through this content. No advisory relationship is created by reading or relying on anything here.
Do your own work. Consult your own licensed counsel, tax advisors, accountants, registered investment advisers, and other qualified professionals before acting on any information. Past performance does not predict future results. Forward-looking statements and projections are inherently uncertain.
Material connections. The author and/or affiliated entities may hold positions in, transact in, or have material relationships with assets, sectors, or companies discussed. Specific holdings are not disclosed.
Securities & offerings. Nothing in this article constitutes an offer to sell, solicitation of an offer to buy, or recommendation regarding any security or interest in any fund, vehicle, or program. Any securities offering, if ever made, would be made only through definitive offering documents and only to eligible persons under applicable law.
© 2026 Marczell Klein Corp, a State of California S-Corporation.
Leave a Reply